REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > (o=)n(=o)-o-c Containing (e.g., Nitrate Ester, Etc.) > Cyano Or Isocyano Bonded Directly To Carbon > Z-c(=o)-o-y, Wherein Z Contains A Benzene Ring > Z Or Y Radical Contains A Nitrogen Atom Z Or Y Radical Contains A Nitrogen AtomZ Or Y Radical Contains A Nitrogen Atom patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/04/07 - 20070004800 - Immunoregulatory compounds and derivatives and methods of treating diseases therewith where R9, R10 and R11 are independently selected from the group consisting of hydrogen and C1 to C4 alkyl, and R12 is selected from the group consisting of hydrogen and —C(O)R13, where R13 is a C1 to C6 alkyl or an aryl group. ... 11/23/06 - 20060264503 - Treating pain using selective antagonists of persistent sodium current The present invention provides methods of treating chronic pain in a mammal by administering to the mammal an effective amount of a selective persistent sodium channel antagonist that has at least 20-fold selectivity for persistent sodium current relative to transient sodium current. ... 10/19/06 - 20060235075 - Analogous compounds of strobilurines and their use as acaricides and insecticides Compounds are described, having general formula (I) and their use as acaricides, insecticides and/or fungicides. ... 09/14/06 - 20060205812 - 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation T is an oxygen atom, a sulfur atom, a sulfonyl group etc.; Q is a hydrogen atom or an optionally substituted lower alkyl group; and Z is a hydrogen atom, a hydroxy group etc., or a pharmaceutically acceptable salt thereof, which exert a potent and selective activated blood coagulation factor ... 07/06/06 - 20060148895 - New composition use and method At least one alkyl paraben is used in an aqueous antimicrobial preservation composition for eliminating or reducing the microbial content of a microbially contaminated separation matrix, which is to be used in a housing of a separation device, the separation matrix being microbially contaminated. Also, in a method of producing ... 05/11/06 - 20060100275 - Agent for treating interstitial cystitis wherein R1 represents hydroxyl group or a lower alkoxy group, or a pharmacologically acceptable salt thereof. Since the phenoxyacetic acid derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof or a hydrate or solvate thereof has a selective β3-adrenoceptor stimulating activity and a remarkable action to ... 05/11/06 - 20060100274 - Therapeutic avenanthramide compounds Methods and compositions are disclosed for reducing pro-inflammatory molecules, adhesion molecules, and vascular smooth muscle cell proliferation, and for increasing NO production. The present invention describes the use of phenolic compositions, purified from oats or synthetically produced, to decrease the effective amount of pro-inflammatory molecules and/or cell adhesion molecules. Alternatively, ... 04/20/06 - 20060084700 - Use of a beta-3 agonist for the treatment of disorders of the prostate and of the lower urogenital tract This invention describes the use of beta-3-adrenoceptor agonists for the treatment of disorders associated with the prostate. These include disorders like those occurring in a prostatitis, where attributable to inflammatory processes or chronic irritation, or disorders like those associated with benign changes of the prostate. The invention is particularly suitable ... 02/16/06 - 20060035969 - Novel modulators of the ppar-type receptors and cosmetic/pharmaceutical compositions comprised thereof and are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology and in the fields of cardiovascular diseases, immune diseases and/or diseases linked to lipid metabolism), or are formulated into cosmetic compositions. ... 02/09/06 - 20060030623 - Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis or its pharmaceutically acceptable salt has excellent antidiabetic effect, anti-obesity effect and anti-arteriosclerosis effect, a medicine containing the compound of formula (1) as the active ingredient is useful as an agent for the prevention or treatment of diabetes (especially non-insulin dependent diabetes mellitus), obesity (especially visceral fat obesity), or arteriosclerosis. ... 12/29/05 - 20050288369 - Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same The present invention relates to novel n-hydroxythiourea, urea and amide compounds as a potent vanilloid receptor antagonist and the pharmaceutical compositions comprising the same. The inventive compound can be useful for analgesics to prevent, alleviate or treat pain diseases or inflammatory disease comprising pain, acute pain, chronic pain, neuropathic pain, ... 11/24/05 - 20050261368 - Preparation of levalbuterol hydrochloride Provided are processes for the preparation of (R)-SLB.D-DBTA salt and levalbuterol hydrochloride. Also provided are levalbuterol hydrochloride degradation products and processes for preparing them. Pharmaceutical compositions comprising at least one levalbuterol hydrochloride of the invention and at least one pharmaceutically-acceptable excipient are also provided. ... 07/28/05 - 20050165096 - Pain management system A method and system is disclosed for treating pain in a body area. After obtaining at least one internal image of the body area using an ultrasound imaging tool, one or more clinically observable factors are determined from the cross section related to the pain in the first body area ... 07/07/05 - 20050148665 - Reagents and method for spatio-temporal control of gene expression by illumination A caged non-steroidal Ecdysone mimetic (NSE) compound and a method for producing free NSE by subjecting the charged NSE to UV irradiation. ... ### FreshPatents.com Support |